Fish Oil Supplementation and Cardiovascular Disease Risk in Individuals of Blood Type A and Blood Type O
abstract: The omega-3 fatty acids in fatty fish and fish oil, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA), have been associated with a reduction in risk for cardiovascular disease. Blood type is a known contributor to risk for cardiovascular events. This study evaluated the effect of fi...
Other Authors: | Herring, Dana (Author) |
---|---|
Format: | Dissertation |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/2286/R.I.25146 |
Similar Items
-
Omega-3 supplementation in patients with sepsis: a systematic review and meta-analysis of randomized trials
by: Clara Lu, et al.
Published: (2017-06-01) -
Issues of Fish Consumption for Cardiovascular Disease Risk Reduction
by: Matthew J. Picklo, et al.
Published: (2013-03-01) -
The intake of long chain omega 3 fatty acids through fish versus capsules results in greater increments of their plasma levels
by: Visioli Francesco, et al.
Published: (2004-03-01) -
Quantitative determination of EPA and DHA in fish oil capsules for cardiovascular disease therapy in Indonesia by GC-MS
by: Amelia Lorensia, et al.
Published: (2021-04-01) -
Fish, Fish Oils and Cardioprotection: Promise or Fish Tale?
by: Akshay Goel, et al.
Published: (2018-11-01)